Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Providence Health & Services
Shanghai Junshi Bioscience Co., Ltd.
Sun Yat-sen University
The First Affiliated Hospital of Zhengzhou University
National Cancer Centre, Singapore
Columbia University
UNC Lineberger Comprehensive Cancer Center
Ziekenhuis Oost-Limburg
SCRI Development Innovations, LLC
City of Hope Medical Center
St. Jude Children's Research Hospital
Mayo Clinic
Case Comprehensive Cancer Center
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center